Anti-tumor action of tumor necrosis factor against Bomirski Ab melanoma in hamsters

to related objects

Location: Deutsche Nationalbibliothek Frankfurt am Main

ISSN: 1661-4917

Extent: Online-Ressource

Language: Englisch

Notes: online resource.

Bibliographic citation: Anti-tumor action of tumor necrosis factor against Bomirski Ab melanoma in hamsters ; volume:55 ; number:4 ; day:23 ; month:7 ; year:2007 ; pages:267-279 ; date:08.2007
Archivum immunologiae et therapiae experimentalis ; 55, Heft 4 (23.7.2007), 267-279, 08.2007

Creator: Koszałka, Patrycja
Szmit, Ewa
Myśliwski, Andrzej
Bigda, Jacek

Contributor: SpringerLink (Online service)

DOI: 10.1007/s00005-007-0031-9

URN: urn:nbn:de:101:1-2021061719484188703225

Rights: Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.

Last update: 14.08.2025, 10:59 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.

Show original at data provider

Associated

Koszałka, Patrycja
Szmit, Ewa
Myśliwski, Andrzej
Bigda, Jacek
SpringerLink (Online service)

Other Objects (12)

Golimumab: A Novel Anti-Tumor Necrosis Factor

Aufsatzsammlung

Anti-tumor necrosis factor therapy in inflammatory bowel disease : 15 tables

Update on intravitreal anti-tumor necrosis factor alpha therapies for ocular disorders

Novel therapeutic strategies and modulators of anti-tumor immunity in melanoma

Stat3-mediated Atg7 expression regulates anti-tumor immunity in mouse melanoma

Successful treatment of Cronkhite–Canada syndrome using anti-tumor necrosis factor antibody therapy

Successful treatment with anti-tumor necrosis factor alpha for reactive small-bowel amyloidosis

HDAC6 selective inhibition of melanoma patient T-cells augments anti-tumor characteristics

Gut microbiota dependent anti-tumor immunity restricts melanoma growth in Rnf5 −/− mice

Targeted Anti‐Tumor Immunotherapy Using Tumor Infiltrating Cells

Maslinic acid potentiates the anti-tumor activity of tumor necrosis factor α by inhibiting NF-κB signaling pathway

Factors that influence rheumatologists’ anti-tumor necrosis factor alpha prescribing decisions: a qualitative study

Golimumab: A Novel Anti-Tumor Necrosis Factor

Aufsatzsammlung

Anti-tumor necrosis factor therapy in inflammatory bowel disease : 15 tables

Update on intravitreal anti-tumor necrosis factor alpha therapies for ocular disorders

Novel therapeutic strategies and modulators of anti-tumor immunity in melanoma

Stat3-mediated Atg7 expression regulates anti-tumor immunity in mouse melanoma

Successful treatment of Cronkhite–Canada syndrome using anti-tumor necrosis factor antibody therapy

Successful treatment with anti-tumor necrosis factor alpha for reactive small-bowel amyloidosis

HDAC6 selective inhibition of melanoma patient T-cells augments anti-tumor characteristics

Gut microbiota dependent anti-tumor immunity restricts melanoma growth in Rnf5 −/− mice

Targeted Anti‐Tumor Immunotherapy Using Tumor Infiltrating Cells

Maslinic acid potentiates the anti-tumor activity of tumor necrosis factor α by inhibiting NF-κB signaling pathway

Factors that influence rheumatologists’ anti-tumor necrosis factor alpha prescribing decisions: a qualitative study

Golimumab: A Novel Anti-Tumor Necrosis Factor

Aufsatzsammlung

Anti-tumor necrosis factor therapy in inflammatory bowel disease : 15 tables

Update on intravitreal anti-tumor necrosis factor alpha therapies for ocular disorders

Novel therapeutic strategies and modulators of anti-tumor immunity in melanoma

Stat3-mediated Atg7 expression regulates anti-tumor immunity in mouse melanoma

Successful treatment of Cronkhite–Canada syndrome using anti-tumor necrosis factor antibody therapy

Successful treatment with anti-tumor necrosis factor alpha for reactive small-bowel amyloidosis

HDAC6 selective inhibition of melanoma patient T-cells augments anti-tumor characteristics

Gut microbiota dependent anti-tumor immunity restricts melanoma growth in Rnf5 −/− mice

Targeted Anti‐Tumor Immunotherapy Using Tumor Infiltrating Cells

Maslinic acid potentiates the anti-tumor activity of tumor necrosis factor α by inhibiting NF-κB signaling pathway

Factors that influence rheumatologists’ anti-tumor necrosis factor alpha prescribing decisions: a qualitative study

Cultural heritage institutions wishing to register will find more information here.

Fields marked * need to be filled in.

Username*

Please enter your username

Email*

Please enter your email address

Please do not fill this field

First name

Last name

Password*

Please enter your password

Confirm password*

Please enter the same password

I have read the terms of use and the privacy policy for the collection of personal data and accept them. *

This field is required.

I would like to subscribe to the newsletter of the Deutsche Digitale Bibliothek. See newsletter subscription info.

Account created

Your "My DDB" account has been successfully created. Before you can log in to your account, you must click the confirmation link in the message we just sent to the email address you provided.

Anti-tumor action of tumor necrosis factor against Bomirski Ab melanoma in hamsters

Object Details

References and Relationships

Contributors, Places and Time

Further information

Data provider

Associated

Other Objects (12)

Golimumab: A Novel Anti-Tumor Necrosis Factor

Anti-tumor necrosis factor therapy in inflammatory bowel disease : 15 tables

Update on intravitreal anti-tumor necrosis factor alpha therapies for ocular disorders

Novel therapeutic strategies and modulators of anti-tumor immunity in melanoma

Stat3-mediated Atg7 expression regulates anti-tumor immunity in mouse melanoma

Successful treatment of Cronkhite–Canada syndrome using anti-tumor necrosis factor antibody therapy

Successful treatment with anti-tumor necrosis factor alpha for reactive small-bowel amyloidosis

HDAC6 selective inhibition of melanoma patient T-cells augments anti-tumor characteristics

Gut microbiota dependent anti-tumor immunity restricts melanoma growth in Rnf5 −/− mice

Targeted Anti‐Tumor Immunotherapy Using Tumor Infiltrating Cells

Maslinic acid potentiates the anti-tumor activity of tumor necrosis factor α by inhibiting NF-κB signaling pathway

Factors that influence rheumatologists’ anti-tumor necrosis factor alpha prescribing decisions: a qualitative study

Golimumab: A Novel Anti-Tumor Necrosis Factor

Anti-tumor necrosis factor therapy in inflammatory bowel disease : 15 tables

Update on intravitreal anti-tumor necrosis factor alpha therapies for ocular disorders

Novel therapeutic strategies and modulators of anti-tumor immunity in melanoma

Stat3-mediated Atg7 expression regulates anti-tumor immunity in mouse melanoma

Successful treatment of Cronkhite–Canada syndrome using anti-tumor necrosis factor antibody therapy

Successful treatment with anti-tumor necrosis factor alpha for reactive small-bowel amyloidosis

HDAC6 selective inhibition of melanoma patient T-cells augments anti-tumor characteristics

Gut microbiota dependent anti-tumor immunity restricts melanoma growth in Rnf5 −/− mice

Targeted Anti‐Tumor Immunotherapy Using Tumor Infiltrating Cells

Maslinic acid potentiates the anti-tumor activity of tumor necrosis factor α by inhibiting NF-κB signaling pathway

Factors that influence rheumatologists’ anti-tumor necrosis factor alpha prescribing decisions: a qualitative study

Golimumab: A Novel Anti-Tumor Necrosis Factor

Anti-tumor necrosis factor therapy in inflammatory bowel disease : 15 tables

Update on intravitreal anti-tumor necrosis factor alpha therapies for ocular disorders

Novel therapeutic strategies and modulators of anti-tumor immunity in melanoma

Stat3-mediated Atg7 expression regulates anti-tumor immunity in mouse melanoma

Successful treatment of Cronkhite–Canada syndrome using anti-tumor necrosis factor antibody therapy

Successful treatment with anti-tumor necrosis factor alpha for reactive small-bowel amyloidosis

HDAC6 selective inhibition of melanoma patient T-cells augments anti-tumor characteristics

Gut microbiota dependent anti-tumor immunity restricts melanoma growth in Rnf5 −/− mice

Targeted Anti‐Tumor Immunotherapy Using Tumor Infiltrating Cells

Maslinic acid potentiates the anti-tumor activity of tumor necrosis factor α by inhibiting NF-κB signaling pathway

Factors that influence rheumatologists’ anti-tumor necrosis factor alpha prescribing decisions: a qualitative study

Related objects

Reset password